Couinaud segment analysis
Liver fibro-inflammation (cT1), fat (PDFF) and volume are quantified for individual Couinaud segments. This can assist clinicians in accurately predicting the future liver remnant (FLR) to inform surgical decision making.
Whole liver analysis:
Built on LiverMultiScan technology that provides validated biomarkers of liver health (cT1 and PDFF) across the whole liver and has been shown to predict clinical outcomes4–6. Provides 3D visualization and quantification of whole liver volume.
Supporting clinical decision making:
A study illustrating that pre-treatment assessment could improve post-treatment outcomes included two patients with similar pre-operative characteristics who had liver resection for colorectal liver metastases (CRLM) but different post-operative outcomes (Figure 1).3